Back to Newsroom
Back to Newsroom

Black Bird Biotech Announces Important Wide-Ranging Field Tests of its Disruptive MiteXstreamTM Biopesticide by A Second International Agri-Chemical Distributor Based in the Middle East

Tuesday, 28 September 2021 08:30 AM

FLOWER MOUND, TX / ACCESSWIRE / September 28, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that an international agri-chemical distributor based in the Middle East is scheduled to begin field testing MiteXstreamTM in October 2021, on numerous crops, including tomato, cucumber, eggplant and leafy greens, as mite populations rise. This distributor noted that, due to the ability of mites to build quick resistance to traditional pesticides, a product that kills mites but is not a traditional "poison" is of keen interest.

"Faced with extensive and expensive mite damage to numerous crops throughout the Middle East, farmers in the region are searching for a mite control solution, and the low-cost, high efficacy quality that MiteXstreamTM delivers is on point," said Fabian Deneault, developer of MiteXstreamTM and President of BBBT. "The capacities of MiteXstreamTM are capable of saving literally billions annually in lost crops, and, after nearly three years of testing by third-party cannabis growers, we have yet to see the mites develop any resistance - that is because MiteXstreamTM simply physically kills the pests, and it does so with only food-grade ingredients." Mr. Denault continued by stating that MiteXstreamTM also delivers highly effective control of molds and mildews, including troublesome powdery mildew.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter ( https://twitter.com/BBBT_Corporate ). Also visit BBBT's corporate website, https://blackbirdbiotech.com , for additional information about the company.

Black Bird Biotech, Inc., Tuesday, September 28, 2021, Press release picture

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstreamTM Edge: use through the day of harvest without concern for residual "pesticide" violations, including in state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

Eric Newlan
Vice President
833-223-4204
[email protected]
www.blackbirdbiotech.com

SOURCE: Black Bird Biotech, Inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: